在Takotsubo综合征中心脏性休克:病因和治疗
Ken Kato1, Davide Di Vece2,3, Mari Kitagawa4
1Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Japan. kkatou0424@yahoo.co.jp.
Cardiovascular intervention and therapeutics
|July 22, 2024
概括
塔科茨博综合征 (TTS) 可以通过各种机制引起心脏性休克. 早期识别这些原因对于有效治疗和改善受影响患者的治疗结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 塔科茨博综合征 (TTS) 模仿急性冠状动脉综合征,但是一种独特的心脏疾病.
- 虽然TTS通常是良性的,但可以导致严重的并发症,特别是心脏性休克在1-20%的病例中.
研究的目的:
- 审查当前有关Takotsubo综合征患者心脏性休克原因的知识.
- 在TTS的背景下总结心脏性休克的治疗策略.
主要方法:
- 对Takotsubo综合征和心脏性休克现有研究的文献综述.
- 综合有关病因机制和治疗方法的信息.
主要成果:
- 在TTS中,心脏性休克可能由多种机制引起,包括失效,右心室功能障碍,左心室外流通道阻塞和急性腹.
- 具体机制决定了适当的治疗策略.
结论:
- 在TTS中早期和准确地识别心脏性休克的潜在机制至关重要.
- 根据已识别的机制进行量身定制的治疗对于优化心脏性休克复杂的TTS患者的治疗结果至关重要.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
765
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
765
Heart Failure Drugs: Inotropic Agents
559
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
559
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
414
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
Increased pulse rate
651
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
651
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K


